Navigation Links
Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials
Date:6/4/2011

or sites of disease involvement.  The study was lead by Minetta Liu, M.D., Georgetown Lombardi Comprehensive Cancer Center and will be presented during a poster session on Monday, June 6th, 2011.

Dr. Minetta Liu has provided consulting services to the company. 

About Circulating Tumor Cells

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream.  The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

About CELLSEARCH® CTC Test

CELLSEARCH® is the first and only regulatory-cleared in vitro diagnostic test to capture and count CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer.  The test can be administered at any time during the course of therapy as a routine blood test.  It is used in combination with other tests and a clinician's assessment, to provide a more complete picture of a patient's prognosis.

About Veridex, LLC

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value diagnostic oncology products.  Veridex's IVD products may significantly benefit patients by helping physicians make more informed decisions that enable better patient care.  Veridex's Clinical Research Solutions provide tools and services that may be used for the selection, identification and enumeration of targeted rare cells in peripheral blood for the identification of biomarkers, aiding scientists in their search for new, targeted therapies.  For more information, visit www.veridex.com

About Abiraterone

In the U.S., abiraterone acetate is marketed as ZYTIGA™ by
'/>"/>

SOURCE Veridex, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
2. American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA
3. American Stroke Association Late-Breaking Science Report: Antiplatelet Drug May Be Better Than Aspirin in Preventing Recurrent Strokes
4. American Heart Association Late-Breaking Clinical Trial Report: New Reversible Oral Drug Reduces Cardiac Events in Primary PCI Patients
5. American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis
6. MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
7. MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
8. Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
9. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
10. Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting
11. Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... President and Chief Executive Officer, will present a corporate ... Anthera will present at 4:30PM ET, ... New York City . ... a biopharmaceutical company focused on developing and commercializing products ...
(Date:11/22/2014)... Pennsylvania , 21 de noviembre de 2014 ... de ensayos clínicos externalizados y tecnologías eClinical, ha ... aproximación de ,seguimiento inteligente, para el seguimiento basado ... seguimiento inteligente amplía el concepto del seguimiento basado ... reducción de las visitas de seguimiento o cambio ...
(Date:11/22/2014)... Research and Markets  has announced the addition of the ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... market has been expanding rapidly owing to the improvement ... 2005-2013, sales of recombinant protein drugs available in Chinese ... it is projected that China ...
Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... A 9-year-old boy is now home safe and sound ... the way home from school thanks to the quick thinking ... device called EmSeeQ® by EmFinders that can quickly locate missing ... purchased the EmSeeQ bracelet in October for her son, Jakob, ...
... 2011 Generex Biotechnology Corporation (OTCBB: GNBT) ( ... into a binding letter agreement to license its ... Inc. ( www.amarantus.com ), a California-based biotechnology company, ... exchange for a non-refundable license fee of $10 ...
Cached Medicine Technology:EmSeeQ® Locator Device Aids in Returning Lost Spokane Boy with Autism Safely Back Home in Minutes 2EmSeeQ® Locator Device Aids in Returning Lost Spokane Boy with Autism Safely Back Home in Minutes 3Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 2Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 3Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 4Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 5
(Date:11/24/2014)... November 24, 2014 Global electrophysiology ... billion by 2020, according to a new study ... of cardiac arrhythmias clubbed with growing global geriatric ... market. Though still in the budding stage, the ... in usage rates in the recent times, with ...
(Date:11/24/2014)... Residents of retirement communities in Ohio ... SENIORS GOT TALENT, an annual online talent competition and ... to classic crooners, to seniors partying on a “night ... indeed living young. , “SENIORS GOT TALENT, while still ... prize, has always been about highlighting the vibrancy of ...
(Date:11/24/2014)... The Holiday Inn Westbury - Long ... Children's Association to donate various items consisting of ... other such items.The Association's program is aimed toward helping ... in nursing homes, assisted living facilities and nursing homes. ... being of seniors throughout the Long Island area. The ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/24/2014)... PA (PRWEB) November 24, 2014 "My ... he was trying to cross the street in his ... driver never saw him. I came up with this ... visible at night." , He developed the Safety Lites ... or in low-lighting conditions. The device ensures that motorists ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2
... Therapeutic Focus Through ... Extending the Good Baby Product Line, ... (Nasdaq: BJGP; "BMP Sunstone"; the "Company") today,announced that its ... a non-binding letter of,intent to acquire 75 percent of ...
... babies born with hearing loss, experts note , , FRIDAY, July ... that all newborns be screened for congenital hearing loss. , ... infant,s health care evaluation," U.S. Preventive Services Task Force Chairman ... Colorado Department of Public Health and Environment, said in a ...
... is a Patient Education System that provides hospitals, medical centers and ... accessible using a telephone, pillow speaker, interactive touch screen or computer. ... ... Synergy Broadcast Systems recently launched several new interface options to it's ...
... Ky., July 17 William F. McMurry, a,Nationally ... obtained today final Court approval of a settlement ... by a Kentucky state court,judge. The settlement gives ... of deferred annuities. The Settlement is valued at ...
... Governor,Schwarzenegger and regulators announced a company-friendly settlement ... new lawsuit filed by the Los Angeles,City Attorney ... retroactively,canceling policies when patients got sick. Today,s settlement ... $5 million penalty., "The timing of today,s ...
... GlycoMark(R) Blood Test Now Established to Provide Physicians with Vital ... ... Patients with Diabetes, NEW YORK and WINSTON-SALEM, N.C., July ... Co., Ltd. (Tokyo, Japan),announced today the formation of a new joint ...
Cached Medicine News:Health News:BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co. 2Health News:BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co. 3Health News:All Newborns Should Have Ears Screened, Task Force Says 2Health News:Synergy Broadcast Systems Announces Enhancements to MMDS Patient Education System 2Health News:Synergy Broadcast Systems Announces Enhancements to MMDS Patient Education System 3Health News:William F. McMurry - Lead Class Counsel Obtains $16.4 Million Settlement for Elderly Clients 2Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 2Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 3
50L...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: